Insider · CIK 0001961273

Lamy Patrick

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001961273

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−3,059 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−26.8K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−3,421 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−382 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−11.1K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−48.7K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−64.2K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−84.9K sh	—	—	0
2025-07-01	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−2,000 sh	$52.88	−$106K	29,891
2025-06-30	Akero Therapeutics, Inc.A Award	See Remarks	AAward	+193 sh	$23.87	+$4,606.524	31,891
2025-06-20	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−875 sh	$54.59	−$47.8K	31,698
2025-06-16	Akero Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,000 sh	$19.87	+$39.7K	34,573
2025-06-16	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−1,500 sh	$53.82	−$80.7K	33,073
2025-06-16	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−500 sh	$55.09	−$27.5K	32,573
2025-06-16	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−2,000 sh	—	—	64,182
2025-06-10	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−919 sh	$54.00	−$49.6K	32,573
2025-06-02	Akero Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+4,000 sh	$19.87	+$79.5K	37,492
2025-06-02	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−600 sh	$49.40	−$29.6K	36,892
2025-06-02	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−3,300 sh	$50.46	−$167K	33,592
2025-06-02	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−100 sh	$51.04	−$5,104	33,492
2025-06-02	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−4,000 sh	—	—	66,182
2025-05-22	Akero Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+4,000 sh	$44.37	+$177K	37,492
2025-05-22	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−4,000 sh	$50.00	−$200K	33,492
2025-05-22	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−4,000 sh	—	—	84,904
2025-05-07	Akero Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+8,000 sh	$19.87	+$159K	41,492
2025-05-07	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−4,701 sh	$42.31	−$199K	36,791
2025-05-07	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−3,299 sh	$42.76	−$141K	33,492
2025-05-07	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−8,000 sh	—	—	70,182
2025-03-03	Akero Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,000 sh	$19.87	+$19.9K	34,492
2025-03-03	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−1,000 sh	$48.09	−$48.1K	33,492
2025-03-03	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−1,000 sh	—	—	78,182
2025-01-27	Akero Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+4,000 sh	$19.87	+$79.5K	38,492
2025-01-27	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−5,000 sh	$57.03	−$285K	33,492
2025-01-27	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−4,000 sh	—	—	79,182
2024-12-31	Akero Therapeutics, Inc.A Award	See Remarks	AAward	+234 sh	$19.69	+$4,606.524	34,492
2024-12-16	Akero Therapeutics, Inc.A Award	See Remarks	AAward	+17.4K sh	—	—	35,258
2024-12-16	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−1,000 sh	$29.13	−$29.1K	34,258
2024-12-16	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+52.1K sh	—	—	52,100
2024-12-10	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−925 sh	$30.79	−$28.5K	17,858
2024-06-28	Akero Therapeutics, Inc.A Award	See Remarks	AAward	+221 sh	$19.94	+$4,406.961	18,783
2024-06-11	Akero Therapeutics, Inc.S Sale	See Remarks	SSale	−569 sh	$22.64	−$12.9K	18,562
2023-12-08	Akero Therapeutics, Inc.A Award	See Remarks	AAward	+18.6K sh	—	—	18,570
2023-12-08	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+83.6K sh	—	—	83,564
2023-01-10	Akero Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	−100K sh	—	—	100,000

Recent filings

Accepted (ET)
Dec 94
Lamy Patrick0001193125-25-312099
SEC(opens sec.gov)
Jul 34
Lamy Patrick0000950170-25-094011
SEC(opens sec.gov)
Jul 24
Lamy Patrick0000950170-25-093320
SEC(opens sec.gov)
Jun 204
Lamy Patrick0000950170-25-088206
SEC(opens sec.gov)
Jun 204
Lamy Patrick0000950170-25-088639
SEC(opens sec.gov)
Jun 124
Lamy Patrick0000950170-25-085670
SEC(opens sec.gov)
Jun 44
Lamy Patrick0000950170-25-081774
SEC(opens sec.gov)

Companies

Akero Therapeutics, Inc.See Remarks

Address

C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BLVD, SUITE 350

SOUTH SAN FRANCISCO, CA, 94080